MedTrace Logo

Addition of Proprioceptive Neuromuscular Facilitation to Cardio Respiratory Training Post Stroke

NCT03171012 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-05-11

No results posted yet for this study

Summary

Post-stroke hemiparesis causes sequelae in the limbs and also in the trunk and abdomen structures. The level of physical activity decreases and cardiorespiratory training(CRT) is indicated to this population to improve the functions of several systems (respiratory, cardiovascular, muscular). The application of Proprioceptive Neuromuscular Facility(PNF) would imply in the awareness and greater harmony of the functions performed by the trunk of this individual. The objective of this study is to evaluate the effects of respiratory and trunk characteristics of the PNF associated with Cardiorespiratory training in quality of life, gait, distance traveled, peak oxygen consumption, respiratory muscle strength, thoracic cavity volumes, mobility and diaphragmatic thickness of individuals with post stroke.

Conditions

  • Stroke
  • Chest Wall Disorder
  • Quality of Life

Interventions

OTHER

Lower limbs CRT

cycle ergometer for lower limbs

OTHER

Upper limbs CRT

cycle ergometer for upper limbs

OTHER

Proprioceptive Neuromuscular Facilitation

Proprioceptive Neuromuscular Facilitation patterns will be performed in seated, dorsal, ventral and side.

OTHER

respiration

respiration

Sponsors & Collaborators

  • Universidade Federal do Rio Grande do Norte

    lead OTHER

Principal Investigators

  • RENATA SOUZA, MASTER · Universidade Federal do Rio Grande do Norte

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-19
Primary Completion
2024-12-31
Completion
2026-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03171012 on ClinicalTrials.gov